Product Liability Archive » February, 2008

Product Liability - February, 2008

155 articles

• Senators Push USDA To Step Up Meat Inspection
• Vytorin Class Actions Now Total 85: Merck
• Wyeth Faces Whistleblower Suits Over Prevnar
• MDL Panel Chooses Venue For Contrast Agent Suits
• Win For Federal Preemption And Device Makers
• EPA, ChemCentral Settle Over Explosion
• Baxter Widens Recall As Blood-Thinner Deaths Mount
• Group Says Ruling Proves Thimerosal-Autism Link
• Judge Shakes Head At Scruggs' Requests
• Prosecution Can't Renege On Deal In Body Parts Case
• Study Links Anemia Drugs To Increased Mortality Risk
• Ex-Exec Can Shield Info In Pfizer Whistleblower Spat
• Supplement Tycoon Ordered To Forfeit $33M
• Panel Refuses Chevron's Bid To Toss $2M Award
• FDA Issues Warning Over Popular Denture Cleaners
• Mitsubishi Ordered To Pay $11M In SUV Death Case
• Sen. Grassley Seeks Info On Prodisc Researchers
• Execs Promise Safer Food To Skeptical Lawmakers
• Lilly Objects To Webcast Of Zyprexa Proceeding
• DuPont Vows To Appeal $196M Pollution Ruling
• Jury Finds Wyeth Culpable In Hormone Lawsuit
• Study Advises Tweaking Toxicity Rules For Nanotech
• With Counterfeiting, You Want Govt. In Your Business
• Economic Effect Of Toy Recalls Minimal: Study
• Under Pressure, Pfizer Pulls Jarvik's Lipitor Ads
• Judge Spurns Blast Victims' Bid To Toss BP Plea
• Microsoft Marketing Suit Gets Class Action Status
• FDA Funding For Drug Ad Reviews Faces Debate
• High Court Will Not Hear St. Jude Valve Case
• Nigerian State Drops $23B Tobacco Suit
• Judge Limits Port Authority Sept. 11 Insurance Claims
• High Court Snubs Big Tobacco's Latest Appeal
• Bluetooth Parties Seek Stay Amid Settlement Talks
• Suit Over Bad Whirlpool Fridges To Move Forward
• Federal-Mogul Parties Dispute 2nd Circuit Application
• Prodisc Patient Widens Circle Of Blame
• Justices' Diagnoses Vary in FDA Preemption Case
• Asarco Wants Court OK For Northwest Settlements
• High Court Aims To Alter Product Liability Landscape
• Dismissal Of Agent Orange Case Upheld
• High Court May Limit Exxon Valdez Punitive Damages
• Seizure Of Cosmetic Signals New Enforcement Trend
• Fruit Products' Health Claims Squeeze Truth: FDA
• Court Nixes Motion To Throw Out "Hot Fuel" MDL
• Welding Fume Judge Denies Bid To Seal Payments
• NYC To Shell Out $6.5M To Ferry Crash Victim
• Lott's Conduct Comes Under Scrutiny
• Lawmakers Demand Answers Over Heparin
• Scope Of Riegel V. Medtronic Is Narrow: Experts
• Mining Company Still On The Hook For Collapse
• Trasylol Study Results Prove Damning For Bayer
• BP Blast Impacts Residents' Health Views: Study
• Asarco $27.9M Settlement Deal Approved
• Kennedy, Waxman Vow To Intercept Medtronic Ruling
• Supreme Court Won't Hear Katrina Insurance Case
• Merck Appealing Canadian OK Of Vioxx Class Action
• Judge Cuts $134M Verdict In Wyeth Hormone Trial
• Once On Cutting Edge, Sharper Image Files For Ch. 11
• Judge Refuses To Ditch Scruggs Bribery Charges
• Plan Gives Trust Too Much Power: ACandS Creditor
• Sears Turns Down Heat On Stove Dispute
• Judge Approves Congoleum's Disclosure Statement
• French Prosecutor To Appeal Queen Mary 2 Verdict
• CBS Concludes Drawn-Out Superfund Dispute
• High Court Limits Device Liability With Medtronic
• Huge Meat Recall Spurs Inspections, Criminal Charges
• Glitch Left Chinese Heparin Plant Uninspected
• Plaintiff Denied Class Status In Wyeth Hormone Suit
• FDA Pitches Off-Label Rules Amid Criticism
• Researcher Claims Bayer's Inaction Cost Lives
• Blast Victims Lobby To Boost BP's Fine By Billions
• Wyeth Claims Victory In Thimerosal-Autism Case
• Generic Version Of J&J Pain Patches Recalled
• Lawmakers Bridge Divide Over CPSC Overhaul Bill
• Appeals Court To Reconsider VW Fatality Case
• Organic Grower Sues Suppliers Over Salmonella
• Sanofi Accused Of Fraud In Clinical Trial Of Drug
• Lawyers In Valdez Case Get Extra Minutes To Argue
• Lawmakers Ask For Investigation Into Meat Safety
• Heparin Problems Renew Questions Of Liability
• Fire Hazard Recall Prompts Toy Helicopter Patent Suit
• The FCPA And The Health Care Industry
• Smith & Nephew Salesman Excused From Liability Suit
• Chinese Pharma Factory Not Inspected By FDA
• NRC Amends Rules On Worker Reports, Labeling
• CDC Urges Action On Toxic Trailers Before Summer
• Plan Reduces Legal Risk For Drs. Who Report Errors
• Heller Ehrman Report Confirms Tersigni Overbilling
• Scruggs Seeks Judge's Recusal In Contempt Case
• Court Freezes Out Plaintiffs In P&G HeatWrap Suit
• Drugmakers Cleared Of Methamphetamine Liability
• Restructuring Import Contracts For Chinese Goods
• Clear Channel Reaches $22M Deal Over 2003 Fire
• J&J Recalls Pain Patches For Fatal Overdose Risk
• Lilly Wins Bid To Shift Zyprexa Whistleblower Suit
• Lamisil Poses Serious Health Risks: Report
• Study Says Bayer's Trasylol Safe For Some Patients
• Lawmaker Calls For Leavitt To Be Punished
• Lawyers Push For $45M Cut Of Guidant Settlement
• Grocers Must Face Dyed Salmon Claims
• Grace Seeks Extension Of $250M DIP Financing
• U.S. Must Pay For WWII Plane-Gas Cleanup: Judge
• Lawmakers Keep Merck, Schering-Plough In Hot Seat
• Senate Backs Bush On Eavesdropping Program
• Samsung Sued Over Defective Blu-Ray Players
• Baxter Halts Production Of Multidose Heparin Vials
• Vytorin Class Actions Pile Up Against Merck, Schering
• Recent Pharmaceutical Cost Reimbursement Litigation
• Teflon Consumers Call For Sanctions Against DuPont
• TJX Fights Transfer Of Class Action To State Court
• Court Assesses $13M Damages In Fatal QM2 Mishap
• NHTSA Probes Two GM SUV Engine Fires
• VW Partly Liable In $10M Drunken Driving Award: Jury
• Ethicon Suffers Blow In Aortic Laceration Case
• Roetzel & Andress Gains Product Liability Veteran
• "Signature Disease" Status Doesn't Change Analysis
• FDA Study Of Botox Safety Deepens Allergan's Frown
• Wyeth Pressure May Have Led To FDA Vet Dismissal
• Congoleum, Bondholders Sign On To New Plan
• Victims Launch Campaign Against Exxon Valdez
• Deaths Prompt FDA Crackdown On Colchicine
• Lawmakers Probe Cos. Behind Lipitor-Touting Doc
• Cos., Execs Indicted Over Tainted Pet Foods
• Welders Drop Medical Monitoring Claims From MDL
• Judge Lets $134M Prempro Verdict Stand
• BP Refinery Probed Over Latest Texas City Accident
• Arco Agrees To $187M Superfund Cleanup Settlement
• Europe Looks To Simplify Cosmetics Oversight
• EPA Nanomaterials Program: Issues, Strategies
• Ford Recalls 225,000 Vehicles To Repair Its Repairs
• Tobacco Case A Contender For Supreme Court Review
• NRC Launches Probe Of Covidien Unit
• Inadvertent E-Mail Led To Scoop On Lilly Deal: Report
• Watchdog Says CPSC Fails To Notify Public Promptly
• Study Warns Of Potential Hazard In Baby Products
• Evenflo Recalls 1 Million Infant Car Seats
• Ford Must Fork Over $6.5M To Rollover Victim
• Victims Have Their Say In BP Refinery Blast Suit
• CPSC Readies Long-Awaited Fire Safety Standards
• FDA Uneasy About Long-Form Zyprexa Side Effect
• $6.8M Fee Award Order Vacated In Sulfur Fuel MDL
• Drug Study Finds Cypher, Taxus Stents Equally Safe
• TV Co. Agrees To Pay $30M To Put Out Fire Suit
• White House Calls For FDA Budget Increase To $2.4B
• DOJ Passes On Katrina Whistleblower Suit
• A Matter Of FACTA: Legal And Legislative Crossroads
• Bush Raises Ire With EPA Budget
• Lead Paint Manufacturers Appeal RI Verdict
• Link Between Chantix, Psych Symptoms Likely: FDA
• Judge Nixes Paxil Warning-Label Suit Against Glaxo
• Court Reinstates $79.5M Verdict Against Philip Morris
• Biovail Faces Grand Jury Probe On Cardizem Launch
• Merck May Face Criminal Probe On Vioxx: Report
• Court Orders New Trial In $28B Philip Morris Case
• Anti-Epilepsy Drugs Increase Suicide Risk: FDA